An Analysis of the Clinical Medication Rules of Traditional Chinese Medicine for Polycystic Ovary Syndrome Based on Data Mining
- PMID: 36865746
- PMCID: PMC9974250
- DOI: 10.1155/2023/6198001
An Analysis of the Clinical Medication Rules of Traditional Chinese Medicine for Polycystic Ovary Syndrome Based on Data Mining
Abstract
Objective: The aim of the present study is to investigate the rules and characteristics of the clinical administration of traditional Chinese medicine (TCM) in the treatment of polycystic ovary syndrome (PCOS) using data mining methods.
Method: Medical cases of well-known contemporary TCM doctors treating PCOS were collected from the China National Knowledge Infrastructure, Chinese Biomedical Literature Service System, Wanfang, Chinese Scientific Journals Database, and PubMed; the data were then characterized, and a standardized database of medical cases was built. This database was used to (1) count the frequency of syndrome types and the herbs used in medical cases by data mining methods and (2) analyze drug association rules and systematic clustering methods.
Results: A total of 330 papers were included, involving 382 patients and a total of 1,427 consultations. The most common syndrome type was kidney deficiency; sputum stasis was the core pathological product and causative factor. A total of 364 herbs were used. Among them, 22 herbs were used >300 times, including Danggui (Angelicae Sinensis Radix), Tusizi (Semen Cuscutae), Fuling (Poria), Xiangfu (Nutgrass Galingale Rhizome), and Baizhu (Atractylodis Macrocephalae Rhizoma). Additionally, 22 binomial associations were obtained from the analysis of association rules; five clustering formulae were obtained via the analysis of high-frequency drug clusters; and 27 core combinations were obtained by k-means clustering of formula.
Conclusion: In the treatment of PCOS, TCM is primarily employed as a combination approach involving tonifying the kidneys, strengthening the spleen, eliminating damp and dissolving phlegm, activating blood circulation, and resolving blood stasis. The core prescription is primarily a compound intervention based on the Cangfu Daotan pill, Liuwei Dihuang pill, and Taohong Siwu decoction.
Copyright © 2023 Dan Xu et al.
Conflict of interest statement
The authors declare that they have no conflicts of interest.
Figures




Similar articles
-
[Study on drug properties and syndrome-symptom-formula-herb network of traditional Chinese medicine in treatment of effort angina pectoris based on data visualization].Zhongguo Zhong Yao Za Zhi. 2020 Sep;45(18):4482-4489. doi: 10.19540/j.cnki.cjcmm.20200115.504. Zhongguo Zhong Yao Za Zhi. 2020. PMID: 33164379 Chinese.
-
[Prescription and medication rules of traditional Chinese medicine for prevention and treatment of diabetic microangiopathy based on literature mining].Zhongguo Zhong Yao Za Zhi. 2023 Sep;48(18):5091-5101. doi: 10.19540/j.cnki.cjcmm.20230604.501. Zhongguo Zhong Yao Za Zhi. 2023. PMID: 37802851 Chinese.
-
A Data Mining-Based Study on Medication Rules of Chinese Herbs to Treat Heart Failure with Preserved Ejection Fraction.Chin J Integr Med. 2022 Sep;28(9):847-854. doi: 10.1007/s11655-022-2892-5. Epub 2022 Jul 12. Chin J Integr Med. 2022. PMID: 35829954 Review.
-
[Core prescriptions in treatment of edema by traditional Chinese medicine masters and mechanism prediction].Zhongguo Zhong Yao Za Zhi. 2022 Feb;47(3):764-775. doi: 10.19540/j.cnki.cjcmm.20211103.701. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 35178960 Chinese.
-
A Data Mining-Based Analysis of Medication Rules in Treating Bone Marrow Suppression by Kidney-Tonifying Method.Evid Based Complement Alternat Med. 2019 Feb 3;2019:1907848. doi: 10.1155/2019/1907848. eCollection 2019. Evid Based Complement Alternat Med. 2019. PMID: 30854004 Free PMC article. Review.
Cited by
-
Integrating artificial intelligence into the modernization of traditional Chinese medicine industry: a review.Front Pharmacol. 2024 Feb 23;15:1181183. doi: 10.3389/fphar.2024.1181183. eCollection 2024. Front Pharmacol. 2024. PMID: 38464717 Free PMC article. Review.
-
Exploring the mechanism of Schisandra rubriflora in the treatment of polycystic ovary syndrome based on network pharmacology and molecular docking.J Ovarian Res. 2025 Jan 28;18(1):16. doi: 10.1186/s13048-025-01600-x. J Ovarian Res. 2025. PMID: 39875917 Free PMC article.
-
Huatan Tongmai Yin regulates RFRP-3 to intervene in the "microbe-gut-HPO axis" to treat PCOS-IR rats.Am J Transl Res. 2025 Jul 15;17(7):4879-4893. doi: 10.62347/XGFS9323. eCollection 2025. Am J Transl Res. 2025. PMID: 40821101 Free PMC article.
References
-
- Qian Y., Ma X. Interpretation of diagnosis criteria for polycystic ovary syndrome. Chinese Journal of Practical Gynecology and Obstetrics . 2019;35(03):264–267.
-
- Ding J., Mei S. S., Cai M. C., Zhang D., Yu J. Integrated network pharmacology and clinical study to reveal the effects and mechanisms of bushen huoxue huatan decoction on polycystic ovary syndrome. Evidence-Based Complementary and Alternative Medicine . 2022;2022:16. doi: 10.1155/2022/2635375.2635375 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources